SPRY4 and neoplasm: To further investigate whether SPRY4 overexpression can reduce tumor growth in vivo, SK-MEL-119NRAS* cells were transfected either with empty CD516B-2-Vector or CD516B-2-SPRY4 and subjected to xenograft experiments.